Aurora Cannabis (ACB) positioned to benefit from increasing takeover interest, marijuana rescheduling developments, and strong balance sheet with zero debt and cash reserves. Key risks include regulatory uncertainty, competitive pressures in cannabis market, and execution challenges on potential M&A activity.

Author argues cannabis stocks are poised for growth following Germany's legalization, comparing it favorably to Canada's 2018 legalization which initially drove stock valuations. The post warns against repeating past mistakes from the 2019 and Biden-era rallies that resulted in 75%+ losses, but suggests current catalysts from larger European markets differ from previous hype cycles.